These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19166259)

  • 21. [Global health--the ethical responsibility of the pharmaceutical industry].
    Lassen LC; Thomsen MK
    Ugeskr Laeger; 2006 Sep; 168(36):2994-5. PubMed ID: 16999884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Status of research and development for control of tropical diseases: hypocrisy, indifference or lack of coordination].
    Millet P
    Med Trop (Mars); 2006 Dec; 66(6):542-8. PubMed ID: 17286017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cheap AIDS drugs for developing countries.
    de Boer J
    Trends Cell Biol; 2001 Nov; 11(11):450. PubMed ID: 11684423
    [No Abstract]   [Full Text] [Related]  

  • 24. [The economics of health care in developing countries: what the fight against the AIDS epidemics has changed].
    Moatti JP
    C R Biol; 2008 Dec; 331(12):964-72. PubMed ID: 19027697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceutical companies and global lack of access to medicines: strengthening accountability under the right to health.
    Grover A; Citro B; Mankad M; Lander F
    J Law Med Ethics; 2012; 40(2):234-50. PubMed ID: 22789043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global AIDS: new challenges for health and human rights.
    Farmer P
    Perspect Biol Med; 2005; 48(1):10-6. PubMed ID: 15681875
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug access in poor countries].
    Sebbag R
    Bull Acad Natl Med; 2007 Nov; 191(8):1601-2. PubMed ID: 18666459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Petition fails to reverse massive price rise for AIDS drug.
    Check E
    Nature; 2004 Aug; 430(7001):715. PubMed ID: 15306778
    [No Abstract]   [Full Text] [Related]  

  • 29. Providing affordable essential medicines to African households: the missing policies and institutions for price containment.
    Tetteh Ek
    Soc Sci Med; 2008 Feb; 66(3):569-81. PubMed ID: 18023953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paying a high price for low costs: why there should be no legal constraints on the profits that can be made on drugs for tropical diseases.
    Sonderholm J
    J Med Ethics; 2009 May; 35(5):315-9. PubMed ID: 19407038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exposing nursing students to the marketing methods of pharmaceutical companies.
    Civaner M; Sarikaya O; Alici SU; Bozkurt G
    Nurs Ethics; 2008 May; 15(3):396-410. PubMed ID: 18388173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmaceutical reference pricing in Germany: definition of therapeutic groups, price setting through regression procedure and effects].
    Stargardt T; Schreyögg J; Busse R
    Gesundheitswesen; 2005 Jul; 67(7):468-77. PubMed ID: 16103970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On misery coast. Episode 1: the market of vital drugs].
    Chneiweiss H
    Med Sci (Paris); 2003; 19(8-9):892-4. PubMed ID: 14593623
    [No Abstract]   [Full Text] [Related]  

  • 34. Respecting the right to access to medicines: Implications of the UN Guiding Principles on Business and Human Rights for the pharmaceutical industry.
    Moon S
    Health Hum Rights; 2013 Jun; 15(1):E32-43. PubMed ID: 25006088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intellectual property rights and right of access to medicines].
    Velásquez G
    Med Trop (Mars); 2006 Dec; 66(6):526-8. PubMed ID: 17286013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The devil is in the details: the pharmaceutical industry's use of gifts to physicians as marketing strategy.
    McFadden DW; Calvario E; Graves C
    J Surg Res; 2007 Jun; 140(1):1-5. PubMed ID: 17481979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug therapy, testimony to our world and our time].
    Joly P
    Bull Acad Natl Med; 1991 Jan; 175(1):67-76; discussion 76-8. PubMed ID: 1863859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global health impact: a basis for labeling and licensing campaigns?
    Hassoun N
    Dev World Bioeth; 2012 Dec; 12(3):121-34. PubMed ID: 22314005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AIDS drug price hike prompts calls for intervention.
    Check E
    Nature; 2004 May; 429(6987):6. PubMed ID: 15129244
    [No Abstract]   [Full Text] [Related]  

  • 40. Enforcement costs: some humanitarian alternatives to stronger patent rights.
    Trotter A
    Med Leg J; 2012; 80(Pt 1):22-32. PubMed ID: 22403122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.